4//SEC Filing
Wallace Owen B. 4
Accession 0000899243-20-024982
CIK 0001680581other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:19 PM ET
Size
6.9 KB
Accession
0000899243-20-024982
Insider Transaction Report
Form 4
Wallace Owen B.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2020-09-14−6,350→ 75,592 totalExercise: $7.84Exp: 2029-01-21→ Common Stock (6,350 underlying) - Exercise/Conversion
Common Stock
2020-09-14$7.84/sh+6,350$49,784→ 133,438 total
Footnotes (1)
- [F1]The shares underlying the option are scheduled to vest in equal quarterly installments from January 1, 2019 through December 31, 2022.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001778843
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:19 PM ET
- Size
- 6.9 KB